BridgeMD
New treatment option for Dysmenorrhea Primary
Official title Myofascial Release Technique in Women With Primary Dysmenorrhea
ClinicalTrials.gov ID: NCT06492148
What this study is testing
- What it's testing
- It has been found that women with dysmenorrhea have active trigger points, particularly in the rectus abdominis, oblique abdominal muscles, quadratus lumborum, and paraspinal muscles. The myofascial release technique is a widely used manual therapy method characterized by the application of low-load, long-duration mechanical forces to manipulate the myofascial complex.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 35, women only
You may be able to join if
- Diagnosed with Primary Dysmenorrhea according to the Primary Dysmenorrhea Consensus Guide,
- Having regular menstruation in the last 6 months (28±7 days)
- Those who had menstrual pain between 40 mm and 100 mm according to the Visual Analogue Scale (VAS) in the last 6 months
You likely can't join if
- Diagnosed with Secondary Dysmenorrhea,
- Having given birth,
- Those with serious gastrointestinal, urogynecological, or autoimmune diseases or other chronic pain syndromes,
- Undergoing urogynecological surgery,
- Those who are pregnant or suspected of pregnancy,
- Those who use analgesics or non-pharmacological agents other than NSAIDs for menstrual pain,
See the full eligibility criteria
- Diagnosed with Primary Dysmenorrhea according to the Primary Dysmenorrhea Consensus Guide,
- Having regular menstruation in the last 6 months (28±7 days)
- Those who had menstrual pain between 40 mm and 100 mm according to the Visual Analogue Scale (VAS) in the last 6 months
- Diagnosed with Secondary Dysmenorrhea,
- Having given birth,
- Those with serious gastrointestinal, urogynecological, or autoimmune diseases or other chronic pain syndromes,
- Undergoing urogynecological surgery,
- Those who are pregnant or suspected of pregnancy,
- Those who use analgesics or non-pharmacological agents other than NSAIDs for menstrual pain,
- Those using intrauterine or oral contraceptives,
- Those taking extra supplements such as magnesium, which may affect treatment
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 35 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.